Company Directory / Biotechnology
PublicFor profitBiotechnologyLiège, Belgium, Belgium
Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA specializes in the development of women's health care products.
- Founded
- 1999 27 years ago
- Staff
- 101-250 476 on LinkedIn
- Followers
- 16k on LinkedIn
- Funding
- $183M as listed, USD
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first… Read all
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium. www.mithra.com
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed. 476 people list it on LinkedIn.
Age
27 years old.
Reach
Website ranked #1,726,250 in the world for traffic, about 13k visits a month. 15,776 followers on LinkedIn.
What it does
BiotechnologyHealth CarePharmaceuticalwomen's healthpharmaceutical developmentR&Dcontract manufacturingCDMO
Funding, as listed
$183M raised in total
- Rounds6
- LatestPost ipo debt, Feb 2024
- Latest amountUSD 21,000,000
- Investors4, 3 leading
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Every detail we hold
Everything the source datasets list about Mithra Pharmaceuticals SA, field by field. Contact details are held but never shown.
The company
- Name
- Mithra Pharmaceuticals SA
- Type
- For profit
- Status
- Public
- Founded
- 1999
- Founders
- François Fornieri
- Industry
- Biotechnology
- Categories
- Biotechnology, Health Care, Pharmaceutical
- Specialities
- women's health, pharmaceutical development, R&D, contract manufacturing, CDMO
Where
- City
- Liège
- Region
- Belgium
- Country
- Belgium
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 101-250
- People on LinkedIn
- 476
- LinkedIn followers
- 15,776
- Web traffic rank
- #1,726,250
- Monthly web visits
- 13,238
Funding, as listed
- Total
- $182,681,087 USD
- Rounds
- 6
- Latest round
- Post ipo debt
- Latest round date
- Feb 2024
- Latest amount
- 21,000,000 USD
- Investors
- 4
- Lead investors
- 3
- Listing status
- public
Corporate family
- Acquisitions made
- 2
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Mithra Pharmaceuticals SA may be growing as evidenced by the additional patent granted for NEXTSTELLIS, which indicates an expansion of their intellectual property portfolio. The company has also entered into a licensing agreement with Searchlight Pharma for the commercialization of Donesta in Canada, suggesting an increase in market reach and potential revenue streams. Furthermore, Mithra Pharmaceuticals SA has signed binding general terms with Gedeon Richter to commercialize ESTELLE and Donesta in China, which demonstrates further international expansion and growth in demand for their products.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Biotechnology in Belgium.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,920 companies in Belgium and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.